NCT00528398View on ClinicalTrials.gov

Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

September 30, 1994

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Leukemia
Interventions
DRUG

cytarabine

DRUG

idarubicin

Trial Locations (2)

85006

Banner Good Samaritan Medical Center, Phoenix

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER